The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/17262995

Download in:

View as

General Info

PMID
17262995